Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey

 

escrs app advert

Posters

Search Title by author or title

Refractive changes and asphericity indices in advanced mono-refractive surgery: 4 year follow-up

Poster Details

First Author: A.Almeida BRAZIL

Co Author(s):    G. Landim   R. Leda   E. Feijo   A. Pereira   A. Bittencourt        

Abstract Details

Purpose:

To analyze refractive changes and asphericity indices (Q values) before and after advanced monovision refractive surgery of 4 years follow-up at Ophthalmology Hospital of Anápolis.

Setting:

Department of Refractive Surgery, Ophthalmology Hospital of Anápolis, Anápolis, Goiás, Brazil.

Methods:

This retrospective study analysed cases of presbyopic eyes undergoing advanced mono-refractive surgery (F-CAT) with WaveLight® Allegretto Wave® Eye-Q Laser. Clinical information was collected, including visual acuity, refractive, follow-up time and Q values preoperatively and 48 months postoperatively in 44 eyes.

Results:

There were 22 patients (44 eyes) with mean age 50.14+5.47 years. The mean of uncorrected visual acuity (UVA), best corrected visual acuity (BCVA), astigmatism, add power, Q values and non-dominant eye uncorrected near visual acuity (UNVA) before the F-CAT were 0.35+0.39, 0.99+0.01, -0.61+0.13 diopters (D), 2.08+0.08 D, -0.18+0.29, and 3.45+0.28, respectively. After 4 years follow-up, the mean values were 0.56+0.05, 0.93+0.02, -0.56+0.07 D, 1.19+0.15 D and 1.45+0.14, respectively (p < 0.05). The study showed that 86.4% of patients had a binocular UVA of 20/32 Snellen (0.63 decimal notation) and UNVA J2 (Jaeger chart) or better after the F-CAT.

Conclusions:

Monovision is a method of presbyopic correction in which one eye is corrected for distance vision and the other eye for near vision. Clinical analysis showed a statistically significant difference between refractive changes and Q values before and after the F-CAT even after 4 years follow-up.

Financial Disclosure:

None

Back to Poster listing